BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22398070)

  • 1. Primary tuberculous peritonitis during infliximab therapy for Crohn's disease.
    Bonse-Geuking U; Kraus M
    J Crohns Colitis; 2012 Jul; 6(6):720-3. PubMed ID: 22398070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrotizing external otitis on a Crohn's disease patient treated with infliximab.
    Duque G; Portela F; Migueis MC
    J Crohns Colitis; 2010 Jun; 4(2):215-6. PubMed ID: 21122510
    [No Abstract]   [Full Text] [Related]  

  • 3. Nocardia pneumonia in a patient with Crohn's disease receiving 6-mercaptopurine and infliximab.
    Saleemuddin A; Govender P; Farraye FA
    J Crohns Colitis; 2014 Jul; 8(7):708-9. PubMed ID: 24342764
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of miliary tuberculosis under infliximab in a patient with spondyloarthritis and suspected Crohn's disease.
    Koschny R; Junghanss T; Mischnik A; Karner M; Kreuter M; Roth W; Stremmel W; Merle U
    Z Gastroenterol; 2013 Oct; 51(10):1177-83. PubMed ID: 24122379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legionella pneumophila pneumonia in a pregnant woman treated with anti-TNF-α antibodies for Crohn's disease: a case report.
    Epping G; van der Valk PD; Hendrix R
    J Crohns Colitis; 2010 Dec; 4(6):687-9. PubMed ID: 21122583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study.
    van der Have M; Belderbos TD; Fidder HH; Leenders M; Dijkstra G; Peters CP; Eshuis EJ; Ponsioen CY; Siersema PD; van Oijen MG; Oldenburg B;
    Dig Liver Dis; 2014 Oct; 46(10):881-6. PubMed ID: 25081843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes zoster in Crohn's disease during treatment with infliximab.
    Wang X; Zhao J; Zhu S; Xia B
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):237-9. PubMed ID: 24216569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal: An unusual opportunistic infection mimicking lymphoma in a patient receiving Infliximab for Crohn's disease.
    Ma MX; Parry J; Venugopal K; Jennings M
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1131. PubMed ID: 28557200
    [No Abstract]   [Full Text] [Related]  

  • 9. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: a case report.
    Gibson DJ; Gallagher CG; Doherty GA
    J Crohns Colitis; 2014 Nov; 8(11):1561-2. PubMed ID: 24834815
    [No Abstract]   [Full Text] [Related]  

  • 11. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
    Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
    Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn disease or intestinal fistulising tuberculosis? Diagnosis difficulties in a case treated with infliximab and corticosteroids.
    Cazacu S; Vere CC; Comănescu V; Dumitrescu C; Enache SD; Ciurea T
    Rom J Morphol Embryol; 2009; 50(2):263-8. PubMed ID: 19434321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vulval Crohn's disease with infliximab.
    Preston PW; Hudson N; Lewis FM
    Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease.
    Levesque BG; Sandborn WJ
    Inflamm Bowel Dis; 2011 Jun; 17(6):1443-4. PubMed ID: 21560204
    [No Abstract]   [Full Text] [Related]  

  • 16. Tuberculous peritonitis during infliximab therapy.
    Verhave JC; van Altena R; Wijnands MJ; Roerdink HT
    Neth J Med; 2008 Feb; 66(2):77-80. PubMed ID: 18292611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone.
    Singh SM; Rau NV; Cohen LB; Harris H
    CMAJ; 2004 Oct; 171(9):1063-4. PubMed ID: 15505269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colon cancer after infliximab therapy for Crohn's disease.
    Ferreira F; Lopes S; Macedo G
    BioDrugs; 2010 Dec; 24 Suppl 1():18-21. PubMed ID: 21175230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy.
    Helbling D; Breitbach TH; Krause M
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1393-5. PubMed ID: 12468964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to improve the safety of biologic therapy in Crohn's disease.
    Ferkolj I
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.